Valnoctamide has been used in trials studying the treatment of Mania and Schizoaffective Disorder, Manic Type.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Hydrocodone | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Magnesium sulfate | The therapeutic efficacy of Valnoctamide can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Valnoctamide may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Mirtazapine | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Orphenadrine | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Pramipexole | Valnoctamide may increase the sedative activities of Pramipexole. |
| Ropinirole | Valnoctamide may increase the sedative activities of Ropinirole. |
| Rotigotine | Valnoctamide may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Valnoctamide. |
| Suvorexant | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Thalidomide | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Valnoctamide. |
| Sodium oxybate | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Ethanol | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Valnoctamide may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Alaproclate. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Valnoctamide. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Valnoctamide. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Valnoctamide. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Valnoctamide. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Valnoctamide. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Valnoctamide. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Valnoctamide. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Valnoctamide. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Valnoctamide. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with Valnoctamide. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dosulepin is combined with Valnoctamide. |
| Zopiclone | The risk or severity of adverse effects can be increased when Valnoctamide is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Valnoctamide. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Valnoctamide. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Valnoctamide. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Valnoctamide. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Valnoctamide. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Valnoctamide. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Valnoctamide. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Valnoctamide. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Valnoctamide. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Valnoctamide. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Valnoctamide. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Valnoctamide. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Valnoctamide. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Valnoctamide. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Valnoctamide. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Valnoctamide. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Valnoctamide. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Valnoctamide. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Valnoctamide. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Valnoctamide. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Valnoctamide. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Valnoctamide. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Valnoctamide. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Valnoctamide. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Valnoctamide. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Valnoctamide. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Valnoctamide. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Valnoctamide. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Valnoctamide. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Valnoctamide. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Valnoctamide. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Valnoctamide. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Valnoctamide. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Valnoctamide. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Valnoctamide. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Valnoctamide. |
| Clozapine | The risk or severity of CNS depression can be increased when Clozapine is combined with Valnoctamide. |
| Meprobamate | The risk or severity of CNS depression can be increased when Meprobamate is combined with Valnoctamide. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Valnoctamide. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Valnoctamide. |
| Sulpiride | The risk or severity of CNS depression can be increased when Sulpiride is combined with Valnoctamide. |
| Alprazolam | The risk or severity of CNS depression can be increased when Alprazolam is combined with Valnoctamide. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Valnoctamide. |